April 30, 2018 / 8:28 PM / 3 months ago

BRIEF-Apellis Pharmaceuticals Qtrly Loss Per Share $0.43

April 30 (Reuters) - Apellis Pharmaceuticals Inc:

* APELLIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 BUSINESS UPDATE AND FINANCIAL RESULTS

* APELLIS PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.43

* APELLIS PHARMACEUTICALS - APL-2 IN GEOGRAPHIC ATROPHY AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA ON TRACK TO ADVANCE INTO PHASE 3 TRIALS IN 2H18 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below